Similar articles

• Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy.

  Dam M, Tonin P, De Boni A, Pizzolato G, Casson S, Ermani M, Freo U, Piron L, Battistin L. Dam M, et al. Stroke. 1996 Jul;27(7):1211-4. doi: 10.1161/01.str.27.7.1211. Stroke. 1996. PMID: 8685930 Clinical Trial.
• Behavioural effects in mice of subchronic chlordiazepoxide, maprotiline, and fluvoxamine. I. Social interactions.

  Cutler MG, Rodgers RJ, Jackson JE. Cutler MG, et al. Pharmacol Biochem Behav. 1997 May-Jun;57(1-2):119-25. doi: 10.1016/s0091-3057(96)00135-9. Pharmacol Biochem Behav. 1997. PMID: 9164562
• Technetium-99m DTPA inhalation scintigraphy in patients treated with fluoxetine and maprotiline: preliminary results.

  Capa Kaya G, Durak H, Yemez B, Turhal U, Ozdogan O, Sayit E, Degirmenci B, Derebek E. Capa Kaya G, et al. Eur J Nucl Med. 2000 Sep;27(9):1402-4. doi: 10.1007/s002590000292. Eur J Nucl Med. 2000. PMID: 11007524
• [Tricyclic antidepressant, tetracyclic antidepressant].

  Koyama T, Inoue T. Koyama T, et al. Nihon Rinsho. 2001 Aug;59(8):1513-7. Nihon Rinsho. 2001. PMID: 11519150 Review. Japanese. No abstract available.
• [ Action mechanisms of modern antidepressives].

  Müller WE. Müller WE. Pharm Unserer Zeit. 2004;33(4):288-95. doi: 10.1002/pauz.200400075. Pharm Unserer Zeit. 2004. PMID: 15287689 Review. German. No abstract available.